 |
|
|
| |
Prospective Validation of the Enhanced Liver Fibrosis (ELF) Test for the Prediction of
Disease Progression in Patients With Nonalcoholic Steatohepatitis and Advanced Fibrosis
|
| |
| |
Reported by Jules Levin
AASLD: The Liver Meeting 2017, October 20-24, 2017, Washington, DC
Stephen A. Harrison,1 Manal F. Abdelmalek,2 Anna Mae Diehl,2 Stephen Caldwell,3 Mitchell L. Shiffman,4 Reem H. Ghalib,5 Eric Lawitz,6 Don C. Rockey,7 Raul E. Aguilar Schall,8 Catherine Jia,8 Bryan J. McColgan,8 Robert P. Myers,8 G. Mani Subramanian,8 John G. McHutchison,8 Andrew J. Muir,2 Vlad Ratziu,9 Nezam H. Afdhal,10 Zachary D. Goodman,11 Jaime Bosch,12 Arun J. Sanyal13
1Pinnacle Clinical Research, San Antonio, TX; 2Duke Clinical Research Institute, Durham, NC; 3University of Virginia, Charlottesville; 4Liver Institute of Virginia, Richmond; 5Texas Clinical Research Institute, Arlington, TX; 6Texas Liver Institute, UT Health, San Antonio; 7Medical University of South Carolina, Charleston; 8Gilead Sciences, Inc., Foster City, CA; 9Hopital Universitaire Pitie Salpetriere, Paris, France; 10Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA; 11Inova Fairfax Hospital, Falls Church, VA; 12Universitat Hospital Clínic de Barcelona, Spain, and Universitätsspital Bern, Switzerland; 13Virginia Commonwealth University, Richmond, VA
References
1. Rosenberg W, et al. Gastroenterology 2004;127:1704-13; 2. Angulo P, et al. Gastroenterology 2013;145:782-9; 3. Fontana R, et al. Hepatology
2008;47:789-98; 4. Parkes J, et al. Gut 2010;59:1245-51; 5. Bowlus C, et al. EASL 2017, abstr FRI-382; 6. Vesterhus M, et al. Hepatology
2015;62:189-97; 7. Sanyal A, et al. EASL 2017, abstr GS-004.
|
| |
|
|
|
|
|
